Reviva Pharmaceuticals Hldg Inc
(RVPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 29,688 | 33,492 | 35,801 | 5,644 | 8,761 |
| TOTAL | $31,404 | $33,894 | $36,535 | $6,656 | $8,762 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 0 | 0 | 2 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $2 | $N/A |
| Total Assets | $31,404 | $33,894 | $36,535 | $6,658 | $8,762 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 510 | 421 | 358 | 471 | 1,008 |
| Accrued Expenses | 1,835 | 553 | 805 | 630 | 325 |
| TOTAL | $2,345 | $974 | $1,163 | $1,101 | $1,333 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 373 | 651 | 851 | 1,040 | 1,964 |
| TOTAL | $373 | $651 | $851 | $1,040 | $1,964 |
| Total Liabilities | $2,718 | $1,625 | $2,014 | $2,142 | $3,297 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 15,133 | 13,982 | 13,389 | 9,232 | 9,232 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -66,832 | -63,147 | -60,868 | -59,259 | -58,310 |
| TOTAL | $28,687 | $32,269 | $34,521 | $4,517 | $5,466 |
| Total Liabilities And Equity | $31,404 | $33,894 | $36,535 | $6,658 | $8,762 |